Comprehensive information about experimentally validated enhancers
| Enhancer ID: | E_04631 |
| Species: | Mus musculus |
| Position : | chr12:113220000-113255414 |
| Year: | 2018 |
| Title: | 3'Igh enhancers hs3b/hs4 are dispensable for Myc deregulation in mouse plasmacytomas with T(12;15) translocations. |
| Genome Build: | mm10 |
| Enhancer Type: | Enhancer |
| Condition: | Disease |
| Disease Name: | plasmacytoma |
| PMID: | 30349647 |
| MONDO: | MONDO:0005615 |
| Tissue: | plasma-cell tumor / hematopoietic tumor context |
| Cell Source: | T(12 |
| Cell Type: | plasma cell |
| Cell Ontology ID: | CL:0000786 |
| Experiment Type: | Enhancer-cluster deletion; tumor-cell functional perturbation; Myc-expression analysis |
| High Throughput Method: | RNA-seq/transcriptome profiling |
| Low Throughput Method: | Cre-mediated 3'RR deletion; qRT-PCR; proliferation; cell-death/apoptosis assays |
| Target gene : | Myc |
| TF name : | NA |
| Regulatory State : | Active |
| GeneName | Pathway Name | Source | Gene Number |
|---|
| Enhancer ID | Position | Tissue | Cell | Disease |
|---|---|---|---|---|
| E_04615 | chr12:113220000-113233375 | plasma-cell tumor / hematopoietic tumor context | plasma cell | plasmacytoma |
| E_04628 | chr12:113220000-113233375 | plasma-cell tumor / hematopoietic tumor context | plasma cell | plasmacytoma |
| E_04629 | chr12:113220000-113233375 | plasma-cell tumor / hematopoietic tumor context | plasma cell | plasmacytoma |
| E_04632 | chr12:113220000-113255414 | plasma-cell tumor / hematopoietic tumor context | plasma cell | plasmacytoma |
| E_03826 | chr12:113228270-113228366 | spleen | B cell | NA |
| E_03827 | chr12:113232344-113232426 | spleen | B cell | NA |
| E_03828 | chr12:113244662-113244744 | spleen | B cell | NA |
| E_03829 | chr12:113253846-113254040 | spleen | B cell | NA |